核酶是什麼？

（從日波核酸 en釋放，也稱為 RNA 酶或催化 RNA）核酶催化化學反應的 RNA 分子。許多天然核酶催化水解的其中一個自己帶的債券或在其他 Rna，債券的水解，但他們還發現催化轉氨酶活性的核糖體。

生命起源研究的調查人員製作了核酶在實驗室能夠催化自己下非常具體的條件，例如 RNA 聚合酶核酶的合成。誘變和篩選已執行導致的改進的變種，從 2001 年的"一輪-18"聚合酶核酶的分離。"B6.61"是能夠在 24 小時內，直到它分解成其帶債券水解底漆範本中添加最多 20 個核苷酸。

一些核酶可發揮重要作用作為治療藥物，作為酶的裁縫定義 RNA 序列，作為生物感測器，和在功能基因組學和基因發現的應用程式。

進一步閱讀

這篇文章是創作共用署名-相同方式共用授權許可。它使用材料從維琪百科上"核酶"適應所有材料用從維琪百科的文章是創新的知識共用署名-相同方式共用許可證的條款下提供。維琪百科 ® 本身是維琪媒體基金公司的註冊的商標

Recent Ribozyme News

Researchers develop CAD-type tools to engineer RNA control systemsThe computer assisted design (CAD) tools that made it possible to fabricate integrated circuits with millions of transistors may soon be coming to the biological sciences. Researchers at the U.S. Depa...

Officials of Kylin Therapeutics receive an issued patent from USPTOOfficials of Kylin Therapeutics Inc., a leading RNAi company, announced this week that they received an issued patent from the U.S. Patent and Trademark Office.

Scientists create tiny RNA molecule to synthesize proteinsAn extremely small RNA molecule created by a University of Colorado at Boulder team can catalyze a key reaction needed to synthesize proteins, the building blocks of life. The findings could be a subs...

HPA-specific shRNA holds potential as a novel therapeutic strategy for gastric cancerPrevious studies have indicated that the heparanase (HPA) is correlated with histopathological parameters and poor prognosis of gastric cancers. Although their efficiencies in inhibiting the expressio...

Kylin Therapeutics receives notice of allowance for its first U.S. patent applicationOfficials of Kylin Therapeutics Inc., a leading RNAi company, announced that they have received a notice of allowance from the U.S. Patent and Trademark Office for its first U.S. patent application.